Future Perspective After two decades, it seems that the era of conventional PPI may be ending and the one of vonoprazan is beginning in order to obtain a better therapy for H
The images of the Products on the Platform are for illustrative purposes only
We observed a marked decrease of gastric epithelial cell proliferation rates, protection against parietal cell death and a 90% reduction of gastritis, accompanied by normalized expression levels for all (pro-inflammatory) cytokines, confirming the suppression of the host immune response elicited by Helicobacter infection
doi: 10.4049/jimmunol.177.3.1393
In addition, because BPC-157 is a gastric peptide, there have been some informal reports of digestive side effects like nausea, diarrhea, appetite changes, gas and bloating related to its administration